33 related articles for article (PubMed ID: 847240)
1. High incidence of imperforate vagina in ADGRA3-deficient mice.
Kvam JM; Nybo ML; Torz L; Sustarsic RK; Jensen KHR; Nielsen JE; Frederiksen H; Gadgaard S; Spiess K; Poulsen SS; Thomsen JS; Cowin P; Blomberg Jensen M; Kurita T; Rosenkilde MM
BMC Biol; 2024 Apr; 22(1):77. PubMed ID: 38589878
[TBL] [Abstract][Full Text] [Related]
2. Effects of dexamethasone on progesterone and estrogen profiles and uterine progesterone receptor localization during pregnancy in Sahel goat in Semi-Arid region.
Yahi D; Ojo NA; Mshelia GD
J Anim Sci Technol; 2017; 59():12. PubMed ID: 28560047
[TBL] [Abstract][Full Text] [Related]
3. Post-conceptional induction of menses with a single vaginal suppository of (15S)-15-methyl prostaglandin F2 alpha methyl ester.
Scher J; Jeng DY; Kerenyi TD
Prostaglandins; 1980 Sep; 20(3):469-79. PubMed ID: 6252575
[TBL] [Abstract][Full Text] [Related]
4. Termination of very early pregnancy by vaginal suppositories-(15S)-15-methyl prostaglandin F2 alpha methyl ester.
Wan LS; Stiber AJ; Turkel J
Contraception; 1981 Dec; 24(6):603-15. PubMed ID: 6173156
[TBL] [Abstract][Full Text] [Related]
5. Termination of early pregnancy by a single-dose 3.0 mg 15-methyl PGF2alpha methyl ester vaginal suppository.
Mandelin M
Prostaglandins; 1978 Jul; 16(1):143-52. PubMed ID: 704921
[TBL] [Abstract][Full Text] [Related]
6. Cervical dilatation with prostaglandin analogues prior to vaginal termination of first trimester pregnancy in nulliparous patients.
Karim SM; Choo HT; Cheng P
Prostaglandins; 1975 Apr; 9(4):631-8. PubMed ID: 1153813
[TBL] [Abstract][Full Text] [Related]
7. Termination of early gestation with (15S)-15-methyl prostaglandin F2 alpha methyl ester vaginal suppositories.
Marrs RP; Brenner PF; Roy S; Mishell DR
Contraception; 1981 Dec; 24(6):617-30. PubMed ID: 6173157
[TBL] [Abstract][Full Text] [Related]
8. Effect of 15(s)15-methyl-PGF2alpha-methyl ester vaginal suppositories on circulating hormone levels in early pregnancy.
Puri CP; Laumas V; Agarwal N; Zoremthangi ; Hingorani V; Laumas KR
Prostaglandins; 1977 Feb; 13(2):363-73. PubMed ID: 847240
[TBL] [Abstract][Full Text] [Related]
9. The current status of prostaglandins as abortifacients.
Brenner WE
Am J Obstet Gynecol; 1975 Oct; 123(3):306-28. PubMed ID: 810025
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive methods for termination of second trimester pregnancy.
Bygdeman M
Baillieres Clin Obstet Gynaecol; 1990 Jun; 4(2):351-9. PubMed ID: 2225604
[TBL] [Abstract][Full Text] [Related]
11. Mifepristone (RU486) alone or in combination with a prostaglandin analogue for termination of early pregnancy: a review.
Avrech OM; Golan A; Weinraub Z; Bukovsky I; Caspi E
Fertil Steril; 1991 Sep; 56(3):385-93. PubMed ID: 1894013
[TBL] [Abstract][Full Text] [Related]
12. Uterine contractility during pregnancy and the effect of abortifacient drugs.
Bygdeman M; Swahn ML
Baillieres Clin Obstet Gynaecol; 1990 Jun; 4(2):249-61. PubMed ID: 2225598
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
